Objective: We report the impact of the COVID‐19 pandemic on urological surgeries and hospital policies at two hospitals in Japan and Taiwan. Methods: We retrospectively surveyed the number of surgeries every 3 months in the Urology Department of Kobe University Hospital (KUH), Kobe, Japan before (January 2019–March 2020) and after (April 2020–September 2021) the COVID‐19 outbreak, and in the Urology Department of Shuang Ho Hospital, Taipei Medical University (SHH‐TMU), Taiwan before (January 2021–March 2021) and after (April 2021–September 2021) the outbreak, and compared the averages and types of surgery. Results: In Kobe, COVID‐19 patients were stratified such that other regional hospitals gave priority to treating COVID‐19 while KUH gave priority to treating non‐COVID‐19 patients. In KUH, the number of surgeries did not change significantly, 237.2 ± 29.6 versus 246.3 ± 20.8 (p = 0.453). In Taiwan COVID‐19 patients increased sharply in May 2021, and teaching hospitals in Taiwan were obliged to provide 20% of their total beds for COVID‐19 patients. At SHH‐TMU, there was a 33.3% drop in the number of surgeries during April–June 2021 compared to the pre‐pandemic average. However, no significant changes were observed, 423.4 ± 68.4 versus 373 ± 91.0 (p = 0.298), because of the subsequent success in controlling the COVID‐19 infection. Conclusions: The comparison of infection control measures between the two countries revealed that while both KUH and SHH‐TMU successfully maintained the number of surgeries, the reasons for this were different for each. [ABSTRACT FROM AUTHOR]